Puretech Health plc (PRTC) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Puretech Health proposes $100m capital return
19 March 2024 09:46
(Sharecast News) - Biotherapeutics company PureTech Health has proposed a capital return of $100.0m to its shareholders by way of a tender offer.
-
US Royalty Pharma strikes deal with PureTech Health on KarXT royalties
23 March 2023 07:24
(Sharecast News) - US-listed Royalty Pharma has acquired an interest in PureTech Health's royalty in Karuna Therapeutics' KarXT drug for up to $500m, with $100m in cash up front and up to $400m in...
-
PureTech's Alkili reports success in adolescent ADHD study
6 January 2023 18:31
(Sharecast News) - Clinical-stage biotherapeutics investor PureTech Health announced on Friday today that its digital medicine company Akili, which it founded, announced topline results of the...
-
Puretech Health confirms possible tie-up with Nektar Therapeutics
7 October 2022 07:10
(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
-
Puretech Health confirms possible tie-up with Nektar Therapeutics
7 October 2022 07:10
(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
-
PureTech first-half mixed as it makes good clinical progress
25 August 2022 09:25
(Sharecast News) - PureTech Health reported total first-half revenue of $7.03m on Thursday, up from $5.84m year-on-year.
-
PureTech reports 'Glyph' milestone, disappointing long Covid results
14 June 2022 07:33
(Sharecast News) - PureTech Health said on Tuesday that it had met a milestone in proving its 'Glyph' therapeutic platform, while separately announcing disappointing results from a study into long...
-
PureTech to buy back up to $50m of shares
5 May 2022 10:09
(Sharecast News) - PureTech Health has announced a $50m share buyback programme, sending shares in the FTSE 250 biotech sharply higher.
-
Puretech Health receives $100m from sale of 55% stake in Karuna Therapeutics
10 November 2021 09:15
(Sharecast News) - Biotechnology company Puretech Health has received approximately $100.0m in cash from the sale of a portion of the group's shares in its founded entity Karuna Therapeutics.
-
PureTech Health's Vor wins FDA fast-track approval for cancer drug
10 September 2021 07:38
(Sharecast News) - Clinical stage biotherapeutics firm PureTech Health on Friday said its founded entity, Vor Biopharma, had won US fast track approval for its leukaemia treatment.
-
Tuesday broker round-up
24 August 2021 14:34
(Sharecast News) - Coats: Jefferies starts at buy with 97.0p target price.
-
PureTech in 'strong' position despite swinging to net loss
24 August 2021 07:42
(Sharecast News) - Biotechnology company PureTech Health swung to a loss in its first half, it said on Tuesday, amid rising costs.
Company announcements Announcements
-
$100M Tender Offer
19 March 2024 07:00
PureTech Health
-
$14B Acquisition of PRTC’s Karuna by BMS Completed
18 March 2024 13:32
PureTech Health
-
PDMR Notification RSU Vesting
6 March 2024 07:00
PureTech Health
-
Transaction in Own Shares
8 February 2024 07:00
PureTech Health
-
Transaction in Own Shares
7 February 2024 07:00
PureTech Health
-
Transaction in Own Shares
6 February 2024 07:00
PureTech Health
-
Transaction in Own Shares
5 February 2024 07:00
PureTech Health
-
Transaction in Own Shares
2 February 2024 07:00
PureTech Health
-
Transaction in Own Shares
1 February 2024 07:00
PureTech Health
-
Transaction in Own Shares
31 January 2024 07:00
PureTech Health
-
Transaction in Own Shares
30 January 2024 07:00
PureTech Health
-
Transaction in Own Shares
29 January 2024 17:30
PureTech Health
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.